A Phase I, Randomized, Single-Blind, Crossover Study to Assess the Pharmacodynamics of AZD9977 Following Single-Dose Administration to Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2018
At a glance
- Drugs AZD 9977 (Primary) ; Eplerenone; Fludrocortisone
- Indications Unspecified
- Focus Pharmacodynamics
- Sponsors AstraZeneca
- 12 Feb 2018 Results assessing clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD997 in D6400C00001 and D6400C0004 study, published in the British Journal of Clinical Pharmacology
- 22 Dec 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 16 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.